News & Analysis on Clinical Trial Services & Contract Research And Development
The Charles Stark Draper Laboratory Inc. has inked a three year partnership with Pfizer to create personalised versions of Draper’s Microphysiological Systems (MPS), for cheaper and more effective preclinical testing.
Cytobioscience Inc, has acquired Soluble Therapeutics Inc to expand its high throughput formulation screening capabilities.
The EMA has started reviewing drugs tested by Micro Therapeutic Research Labs after an inspection by Dutch and Austrian regulators identified potential data integrity problems.